LEHI, Utah, April 24, 2024 /PRNewswire/ -- Nature's Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company of premium-quality herbal and nutritional products, today released its 2023 Comprehensive Impact Report. The report showcases Nature's Sunshine's advancements over the past 12 months, demonstrating its ongoing commitment to sustainability across sourcing, supply chain, and manufacturing and its investment in its people and processes. The report illustrates how the implementatio ...

LEHI, Utah, April 23, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company of premium-quality herbal and nutritional products, will conduct a conference call on Tuesday, May 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature’s Sunshine ...

Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q4 2023 Results Conference Call March 12, 2024 5:00 PM ET Company Participants Nate Brower - General Counsel Terrence Moorehead - CEO Shane Jones - CFO Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine Financial Results for the Fourth Quarter and Full Year ended December 31, 2023. Joining us today are Nature's Sunshine's CEO, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________ FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ☐ Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number 001-34483 NATURE'S SUNSHINE PRODUCTS, INC. (Address of principal executive offices and zip code) (801) 341-790 ...

Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results - Fourth Quarter GAAP Net Income More Than Triples to $9 Million, Adjusted EBITDA up 21% to $9.7 Million - LEHI, Utah – March 12, 2024 – Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine" and/or the "Company"), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quar ...

Cautionary Note Regarding Forward-Looking Statements These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption "Risk Factors" in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Form 10-Q. We have included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information con ...

Start Time: 17:00 End Time: 17:25 January 1, 0000 ET Q3 2023 Earnings Conference Call November 07, 2023, 17:00 PM ET Company Participants Terrence Moorehead - CEO Shane Jones - CFO Nathan Brower - General Counsel Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the Third Quarter Ended September 30, 2023. Joining us today are Nature's Sunshine's CE ...

Sales Performance - Consolidated net sales for Q3 2023 were $111.2 million, a 6.4% increase from $104.5 million in Q3 2022, while net sales for the nine months ended September 30, 2023, were $336.4 million, up 5.4% from $319.2 million in the same period last year [103]. - Net sales in Asia for Q3 2023 reached $52.2 million, a 9.1% increase from $47.9 million in Q3 2022, and for the nine months, sales were $153.4 million, up 8.5% from $141.4 million [104]. - In North America, net sales for Q3 2023 were $34.8 million, a 10.4% increase from $31.5 million in Q3 2022, and for the nine months, sales were $104.1 million, up 2.5% from $101.6 million [110]. - In the Taiwan market, net sales increased by $2.1 million (15.8%) for Q3 2023 compared to Q3 2022, attributed to effective sales force execution [106]. - The China market saw a significant increase in net sales of $2.5 million (30.7%) for Q3 2023, driven by the expiration of COVID-19 restrictions and product promotions [108]. - Europe experienced a slight decrease in net sales for Q3 2023, totaling $18.8 million, down 2.9% from $19.3 million in Q3 2022, primarily due to reduced average order sizes [109]. - Latin America and Other markets reported net sales of $5.4 million for Q3 2023, a decrease of 6.4% from $5.8 million in Q3 2022, reflecting customer sensitivity to economic conditions [112]. - The company anticipates continued growth in net sales driven by product sales improvements in Asia and North America, despite challenges from foreign currency fluctuations and inflation [102]. Cost and Expenses - Cost of sales as a percentage of net sales decreased to 26.9% for Q3 2023 from 28.4% in Q3 2022, indicating improved contribution margin initiatives despite inflationary pressures [114]. - Volume incentives as a percentage of net sales were 30.7% for Q3 2023, down from 31.6% in Q3 2022, reflecting changes in promotional activity and sales mix [115]. - Selling, general and administrative expenses increased by $4.5 million to $41.3 million for the three months ended September 30, 2023, and by $12.9 million to $127.2 million for the nine months ended September 30, 2023, compared to the same periods in 2022 [117]. - Selling, general and administrative expenses represented 37.1% and 37.8% of net sales for the three and nine months ended September 30, 2023, respectively, compared to 35.2% and 35.8% for the same periods in 2022 [117]. Cash Flow and Financial Position - Operating activities provided cash of $31.6 million for the nine months ended September 30, 2023, compared to using cash of $2.9 million in the same period in 2022 [132]. - Investing activities used $9.2 million for the nine months ended September 30, 2023, compared to $4.7 million for the same period in 2022 [133]. - Financing activities used $3.4 million for the nine months ended September 30, 2023, compared to $15.3 million in cash for the same period in 2022 [134]. - The company had $76.0 million in cash as of September 30, 2023, with $66.7 million held in foreign markets [130]. Tax and Other Charges - The provision for income taxes was 35.9% for the three months ended September 30, 2023, compared to 92.7% for the same period in 2022 [119]. - A one-time pre-tax charge of $5.8 million was recorded for the nine months ended September 30, 2023, related to a criminal scheme directed at a wholly owned subsidiary [117]. - Other loss, net, for the three months ended September 30, 2023, was $0.9 million, an improvement from a loss of $2.3 million in the same period in 2022 [118]. Share Repurchase - The company repurchased 180,000 shares of common stock for $2.2 million during the nine months ended September 30, 2023 [134].

Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Nathan Brower - General Counsel Terrence Moorehead - CEO Shane Jones - CFO Conference Call Participants Linda Bolton-Weiser - D.A. Davidson Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the Second Quarter Ended June 30, 2023. Joining us today are Nature's Sunshine's CEO, Terrence Moo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF FORM 10-Q (Mark One) For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-34483 NATURE'S SUNSHINE PRODUCTS, INC. (Exact n ...